Cancer is a famously complex disease. Despite sharing the ‘cancer’ label, different cancer types can be as structurally and functionally diverse as the tissues from which they arise—physicians and ...
In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...
Merkel cell carcinoma, or MCC, is so rare that newly diagnosed patients are often the first case their oncologist has ever treated. For many patients, understanding this aggressive skin cancer’s ...
Incidence is increasing faster than melanoma, with typical presentation in the mid-70s and risk amplified by UV exposure, fair skin, immunosuppression, and MCPyV-associated oncogenesis. Accurate ...
ctDNA testing effectively stratifies Merkel cell carcinoma patients into high and low recurrence risk categories, influencing surveillance strategies. The study's cohorts revealed significant ...
Merkel cell carcinoma (MCC) is an aggressive skin cancer with a 40% recurrence rate, lacking effective prognostic biomarkers and surveillance methods. This prospective, multicenter, observational ...
Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...
Megha Padi, PhD, is a member of the University of Arizona Cancer Center and an assistant professor at the U of A College of Science. Merkel cell carcinoma is a rare but fast-growing neuroendocrine ...
BIRMINGHAM, Ala. – Transduction is the changing of one form of energy into another, such as a spoken voice changed into radio waves by a cellphone. Ten years ago, three research teams published a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results